<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="antibody-validation-article" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.8154.2</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Antibody Validation Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                    <subj-group>
                        <subject>Antigen Processing &amp; Recognition</subject>
                    </subj-group>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Monoclonal antibodies against muscle actin isoforms: epitope identification and analysis of isoform expression by immunoblot and immunostaining in normal and regenerating skeletal muscle</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 2; peer review: 3 approved]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Chaponnier</surname>
                        <given-names>Christine</given-names>
                    </name>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Gabbiani</surname>
                        <given-names>Giulio</given-names>
                    </name>
                    <xref ref-type="corresp" rid="c2">b</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Department of Pathology-Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:christine.chaponnier@unige.ch">christine.chaponnier@unige.ch</email>
                </corresp>
                <corresp id="c2">
                    <label>b</label>
                    <email xlink:href="mailto:giulio.gabbiani@unige.ch">giulio.gabbiani@unige.ch</email>
                </corresp>
                <fn fn-type="con">
                    <p>C.C. designed and performed research. C.C. and G.G. wrote the paper.</p>
                </fn>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>The authors sell the anti-actin isoform antibodies to companies through Unitec, University of Geneva, &lt;a href="http://unitec@unige.ch"&gt;unitec@unige.ch&lt;/a&gt;
    </p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>1</day>
                <month>6</month>
                <year>2016</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2016</year>
            </pub-date>
            <volume>5</volume>
            <elocation-id>416</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>25</day>
                    <month>5</month>
                    <year>2016</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2016 Chaponnier C and Gabbiani G</copyright-statement>
                <copyright-year>2016</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/5-416/pdf"/>
            <abstract>
                <p>Higher vertebrates (mammals and birds) express six different highly conserved actin isoforms that can be classified in three subgroups: 1) sarcomeric actins, &#x03b1;-skeletal (&#x03b1;-SKA) and &#x03b1;-cardiac (&#x03b1;-CAA), 2) smooth muscle actins (SMAs), &#x03b1;-SMA and &#x03b3;-SMA, and 3) cytoplasmic actins (CYAs), &#x03b2;-CYA and &#x03b3;-CYA. The variations among isoactins, in each subgroup, are due to 3&#x2013;4 amino acid differences located in their acetylated N-decapeptide sequence. The first monoclonal antibody (mAb) against an actin isoform (&#x03b1;-SMA) was produced and characterized in our laboratory in 1986 (
                    <xref ref-type="bibr" rid="ref-26">Skalli 
                        <italic toggle="yes">et al.</italic>, 1986</xref>). We have further obtained mAbs against the 5 other isoforms. In this report, we focus on the mAb anti-&#x03b1;-SKA and anti-&#x03b1;-CAA obtained after immunization of mice with the respective acetylated N-terminal decapeptides using the Repetitive Immunizations at Multiple Sites Strategy (RIMMS). In addition to the identification of their epitope by immunoblotting, we describe the expression of the 2 sarcomeric actins in mature skeletal muscle and during muscle repair after micro-lesions. In particular, we analyze the expression of &#x03b1;-CAA, &#x03b1;-SKA and &#x03b1;-SMA by co-immunostaining in a time course frame during the muscle repair process. Our results indicate that a restricted myocyte population expresses &#x03b1;-CAA and suggest a high capacity of self-regeneration in muscle cells. These antibodies may represent a helpful tool for the follow-up of muscle regeneration and pathological changes.</p>
                <sec>
                    <title>
						
                        <abbrev>
							
                            <def>
                                <p>&#x03b1;-SMA, &#x03b1;-smooth muscle actin; &#x03b1;-SKA, &#x03b1;-skeletal actin; &#x03b1;-CAA, &#x03b1;-cardiac actin; mAb, monoclonal antibody; PBS, Phosphate Buffered Saline; PFA, paraformaldehyde; TBS, Tris Buffered Saline.</p>
                            </def>
						</abbrev>
					</title>
                </sec>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>Actin isoforms</kwd>
                <kwd>monoclonal antibodies</kwd>
                <kwd>epitope</kwd>
                <kwd>muscle repair</kwd>
            </kwd-group>
            <funding-group>
                <funding-statement>This work was supported by the Swiss National Science Foundation (grant number 310030_125320) to C.C. </funding-statement>
            </funding-group>
        </article-meta>
        <notes>
            <sec sec-type="version-changes">
                <label>Revised</label>
                <title>Amendments from Version 1</title>
                <p>We like to thank all reviewers for their helpful comments. &#x00a0; 
                    <list list-type="bullet">
                        <list-item>
                            <p>A few words have been changed in the new version following the suggestions given by the referees. &#x00a0;</p>
                        </list-item>
                        <list-item>
                            <p>A new figure (Supplemental figure 1) showing the specificity of the antibodies is provided, with raw data of Western blots on different tissue extracts. &#x00a0;</p>
                        </list-item>
                        <list-item>
                            <p>A new figure (Supplemental Figure 2) showing &#x03b1;CAA positive myofibers with centrally located nuclei during muscle regeneration is provided (Enlargement of Figure 2Af and 3Ai).</p>
                        </list-item>
                    </list> We believe that future studies will benefit from our effort to generate these highly specific mAbs against actin isoforms.</p>
            </sec>
        </notes>
    </front>
    <body>
        <sec sec-type="intro">
            <title>Introduction</title>
            <p>Expression of actin isoforms in skeletal muscle at the mRNA and protein levels have been described since the 1980s using tissue extracts (
                <xref ref-type="bibr" rid="ref-11">Gunning 
                    <italic toggle="yes">et al.</italic>, 1983</xref>; 
                <xref ref-type="bibr" rid="ref-12">Hayward &amp; Schwartz, 1986</xref>; 
                <xref ref-type="bibr" rid="ref-13">Hayward 
                    <italic toggle="yes">et al.</italic>, 1988</xref>; 
                <xref ref-type="bibr" rid="ref-18">Minty 
                    <italic toggle="yes">et al.</italic>, 1982</xref>; 
                <xref ref-type="bibr" rid="ref-21">Ordahl, 1986</xref>; 
                <xref ref-type="bibr" rid="ref-22">Paterson &amp; Eldridge, 1984</xref>; 
                <xref ref-type="bibr" rid="ref-24">Sassoon 
                    <italic toggle="yes">et al.</italic>, 1988</xref>; 
                <xref ref-type="bibr" rid="ref-31">Vandekerckhove 
                    <italic toggle="yes">et al.</italic>, 1986</xref>). These studies have indicated that sarcomeric actins (&#x03b1;-CAA and &#x03b1;-SKA) are expressed in fetal and regenerating skeletal muscle, whereas &#x03b1;-SKA becomes the predominant actin isoform in mature skeletal muscle. Noteworthy, during fetal life, another actin isoform, &#x03b1;-SMA, is highly expressed and precedes the sarcomeric isoforms (
                <xref ref-type="bibr" rid="ref-2">Bochaton-Piallat 
                    <italic toggle="yes">et al.</italic>, 1992</xref>; 
                <xref ref-type="bibr" rid="ref-12">Hayward &amp; Schwartz, 1986</xref>; 
                <xref ref-type="bibr" rid="ref-17">McHugh 
                    <italic toggle="yes">et al.</italic>, 1991</xref>; 
                <xref ref-type="bibr" rid="ref-32">Woodcock-Mitchell 
                    <italic toggle="yes">et al.</italic>, 1988</xref>).</p>
            <p>Nevertheless, very little is known concerning the precise localization of these isoforms due to the lack of specific &#x03b1;-SKA and &#x03b1;-CAA antibodies. The first mAb against &#x03b1;-CAA has allowed the identification, by immunohistochemistry, of a &#x03b1;-CAA transient expression in human skeletal muscle satellite cells during skeletal regeneration induced by muscle injury, while normal skeletal muscle was negative (
                <xref ref-type="bibr" rid="ref-10">Franke 
                    <italic toggle="yes">et al.</italic>, 1996</xref>). Ten years later, the same group, in a more extensive study, has further analyzed the expression and localization of &#x03b1;-CAA in normal, regenerating, diseased and neoplastic human muscle tissues (
                <xref ref-type="bibr" rid="ref-20">Moll 
                    <italic toggle="yes">et al.</italic>, 2006</xref>). In human fetal skeletal muscle, a uniform strong &#x03b1;-CAA staining was observed while in normal adult skeletal muscle, &#x03b1;-CAA was identified only in few thin fibers. &#x03b1;-CAA staining of thin fibers became stronger in human regenerating skeletal muscle after traumatic injury, as well as in Duchenne muscular dystrophy (DMD). Whether the persistence of &#x03b1;-CAA in DMD myofibers is due to a lack of differentiation or to a regenerative process deserves further examination. Interestingly, resting satellite cells in healthy adult muscle lack this isoform, whereas, when satellite cells are activated during the regeneration process, &#x03b1;-CAA is up-regulated. Unfortunately, in these two studies, a comparative &#x03b1;-SKA staining was not performed.</p>
            <p>In a more recent study, the switch of &#x03b1;-CAA to &#x03b1;-SKA during the differentiation of skeletal muscle from mouse embryonic stem cells has been examined (
                <xref ref-type="bibr" rid="ref-19">Mizuno 
                    <italic toggle="yes">et al.</italic>, 2009</xref>). In this 
                <italic toggle="yes">in vitro</italic> system, &#x03b1;-CAA appeared first in myoblasts, with no staining for &#x03b1;-SKA. During cell fusion, &#x03b1;-SKA appeared. When myotubes began to form sarcomeres, &#x03b1;-SKA expression increased while &#x03b1;-CAA began to decrease. Finally, mature skeletal muscle fibers were mainly composed of &#x03b1;-SKA. Although, this 
                <italic toggle="yes">in vitro</italic> system seems to recapitulate the 
                <italic toggle="yes">in vivo</italic> skeletal muscle differentiation at the level of sarcomeric actins switching, the 
                <italic toggle="yes">in vivo</italic> origin of progenitor cells during 
                <italic toggle="yes">in vivo</italic> muscle differentiation/repair remains elusive.</p>
            <p>The sequential expression of the two striated actins during: i) heart development (high expression of &#x03b1;-SKA at birth, predominant expression of &#x03b1;-CAA in differentiated cardiac muscle at adult life) and ii) skeletal muscle development (high expression of &#x03b1;-CAA at birth, predominant of &#x03b1;-SKA in differentiated skeletal muscle at adult life) has been known from mRNA studies for decades, but little is known about the distribution and/or the localization of the two &#x03b1;-sarcomeric muscle actins, because of the lack of double immunostainings availability. Nevertheless, our laboratory, in collaboration with others, has studied &#x03b1;-SKA expression and distribution, in particular in developing and pathological hearts, using affinity polyclonal antibodies (
                <xref ref-type="bibr" rid="ref-6">Cl&#x00e9;ment 
                    <italic toggle="yes">et al.</italic>, 1999</xref>), again without double immunostaining.</p>
            <p>As mentioned above, &#x03b1;-CAA distribution has been studied during muscle development and repair (
                <xref ref-type="bibr" rid="ref-20">Moll 
                    <italic toggle="yes">et al.</italic>, 2006</xref>), but a comparative study with &#x03b1;-SKA was still missing. Our mAbs were raised using the acetylated N-terminus decapeptide of each isoform (see 
                <xref ref-type="table" rid="T1">Table 1</xref>). The two different mAb subtypes (anti-&#x03b1;-SKA, IgG2b and anti-&#x03b1;-CAA, IgG1), allowed a clear analysis of the expression and distribution of the two actin isoforms in mature skeletal muscle and during regeneration after micro-lesions by means of highly specific anti- mouse subtype secondary antibodies.</p>
            <table-wrap id="T1" orientation="portrait" position="anchor">
                <label>Table 1. </label>
                <caption>
                    <title>List of monoclonal antibodies against the 6-actin isoforms raised in our laboratory.</title>
                    <p>The epitope recognized by each antibody is enlightened in bold.</p>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <thead>
                        <tr>
                            <th align="left" colspan="1" rowspan="1">Actin isoform</th>
                            <th align="left" colspan="1" rowspan="1">Immunogen</th>
                            <th align="left" colspan="1" rowspan="1">MAb name</th>
                            <th align="left" colspan="1" rowspan="1">Clone</th>
                            <th align="left" colspan="1" rowspan="1">Subtype</th>
                            <th align="left" colspan="1" rowspan="1">Original Reference</th>
                            <th align="left" colspan="1" rowspan="1">Distributors</th>
                            <th align="left" colspan="1" rowspan="1">Catalog Number</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td colspan="1" rowspan="1" valign="top">&#x03b1;-SMA</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <bold>
                                    <underline>AcEEED</underline>
                                </bold>STALVC</td>
                            <td colspan="1" rowspan="1" valign="top">Anti-&#x03b1;-SM1</td>
                            <td colspan="1" rowspan="1" valign="top">1A4</td>
                            <td colspan="1" rowspan="1" valign="top">IgG2a</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <xref ref-type="bibr" rid="ref-27">Skalli 
                                    <italic toggle="yes">et al.</italic>, 1986</xref>
                            </td>
                            <td colspan="1" rowspan="1" valign="top">Abcam
                                <break/>AbD Serotec
                                <break/>Cell Marque Corporation
                                <break/>Dako
                                <break/>eBioscience
                                <break/>EMD Millipore
                                <break/>Genemed Biotechnologies
                                <break/>Nordic-MUbio
                                <break/>R&#x00a7;D Systems
                                <break/>Santa Cruz Biotechnology
                                <break/>Sigma-Aldrich
                                <break/>Spring Bioscience
                                <break/>Zeta Corporation</td>
                            <td colspan="1" rowspan="1" valign="top">ab-7817
                                <break/>MCA5781GA
                                <break/>202M
                                <break/>M0851
                                <break/>14&#x2013;9760
                                <break/>113200
                                <break/>61&#x2013;0001
                                <break/>MUB0107S
                                <break/>MAB1420
                                <break/>sc-32251
                                <break/>A5228
                                <break/>E14344
                                <break/>Z2066</td>
                        </tr>
                        <tr>
                            <td colspan="1" rowspan="1" valign="top">&#x03b3;-SMA</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <bold>
                                    <underline>AcEEETTALV</underline>
                                </bold>C</td>
                            <td colspan="1" rowspan="1" valign="top">Anti-&#x03b3;-SMA</td>
                            <td colspan="1" rowspan="1" valign="top">20D2</td>
                            <td colspan="1" rowspan="1" valign="top">IgG1</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <xref ref-type="bibr" rid="ref-1">Arnoldi 
                                    <italic toggle="yes">et al.</italic>, 2013</xref>
                            </td>
                            <td colspan="1" rowspan="1" valign="top">NA</td>
                            <td colspan="1" rowspan="1" valign="top">NA</td>
                        </tr>
                        <tr>
                            <td colspan="1" rowspan="1" valign="top">&#x03b2;-CYA</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <bold>
                                    <underline>AcDDDI</underline>
                                </bold>AALVC</td>
                            <td colspan="1" rowspan="1" valign="top">Anti-&#x03b2;-CYA</td>
                            <td colspan="1" rowspan="1" valign="top">4C2</td>
                            <td colspan="1" rowspan="1" valign="top">IgG1</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <xref ref-type="bibr" rid="ref-9">Dugina 
                                    <italic toggle="yes">et al.</italic>, 2009</xref>
                            </td>
                            <td colspan="1" rowspan="1" valign="top">AbD Serotec
                                <break/>EMD Millipore
                                <break/>Nordic-MUbio</td>
                            <td colspan="1" rowspan="1" valign="top">MCA5775GA
                                <break/>MABT825
                                <break/>MUB0110S</td>
                        </tr>
                        <tr>
                            <td colspan="1" rowspan="1" valign="top">&#x03b3;-CYA</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <bold>
                                    <underline>AcEEEIAAL</underline>
                                </bold>VC</td>
                            <td colspan="1" rowspan="1" valign="top">Anti-&#x03b3;-CYA</td>
                            <td colspan="1" rowspan="1" valign="top">2A3</td>
                            <td colspan="1" rowspan="1" valign="top">IgG2b</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <xref ref-type="bibr" rid="ref-9">Dugina 
                                    <italic toggle="yes">et al.</italic>, 2009</xref>
                            </td>
                            <td colspan="1" rowspan="1" valign="top">AbD Serotec
                                <break/>EMD Millipore
                                <break/>Nordic-MUbio</td>
                            <td colspan="1" rowspan="1" valign="top">MCA5776GA
                                <break/>MABT824
                                <break/>MUB0111S</td>
                        </tr>
                        <tr>
                            <td colspan="1" rowspan="1" valign="top">&#x03b1;-SKA and &#x03b1;-CAA
                                <break/>Sarcomeric actins</td>
                            <td colspan="1" rowspan="1" valign="top">Rabbit skeletal actin</td>
                            <td colspan="1" rowspan="1" valign="top">Anti-&#x03b1;-SR1</td>
                            <td colspan="1" rowspan="1" valign="top">5C5</td>
                            <td colspan="1" rowspan="1" valign="top">IgM</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <xref ref-type="bibr" rid="ref-26">Skalli 
                                    <italic toggle="yes">et al.</italic>, 1988</xref>
                            </td>
                            <td colspan="1" rowspan="1" valign="top">Dako
                                <break/>Santa Cruz Biotechnology
                                <break/>Sigma-Aldrich
                                <break/>Spring Bioscience</td>
                            <td colspan="1" rowspan="1" valign="top">M0874
                                <break/>sc-58670
                                <break/>A 2172
                                <break/>E16654</td>
                        </tr>
                        <tr>
                            <td colspan="1" rowspan="1" valign="top">&#x03b1;-SKA</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <bold>
                                    <underline>AcDEDETTA</underline>
                                </bold>LVC</td>
                            <td colspan="1" rowspan="1" valign="top">Anti-&#x03b1;-SKA</td>
                            <td colspan="1" rowspan="1" valign="top">3B3</td>
                            <td colspan="1" rowspan="1" valign="top">IgG1</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <xref ref-type="bibr" rid="ref-8">Driesen 
                                    <italic toggle="yes">et al.</italic>, 2009</xref>
                            </td>
                            <td colspan="1" rowspan="1" valign="top">Nordic-MUbio</td>
                            <td colspan="1" rowspan="1" valign="top">MUB0108S</td>
                        </tr>
                        <tr>
                            <td colspan="1" rowspan="1" valign="top">&#x03b1;-SKA</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <bold>
                                    <underline>AcDEDETTA</underline>
                                </bold>LVC</td>
                            <td colspan="1" rowspan="1" valign="top">Anti-&#x03b1;-SKA</td>
                            <td colspan="1" rowspan="1" valign="top">10D2</td>
                            <td colspan="1" rowspan="1" valign="top">IgG2a</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <xref ref-type="bibr" rid="ref-8">Driesen 
                                    <italic toggle="yes">et al.</italic>, 2009</xref>
                            </td>
                            <td colspan="1" rowspan="1" valign="top">NA</td>
                            <td colspan="1" rowspan="1" valign="top">NA</td>
                        </tr>
                        <tr>
                            <td colspan="1" rowspan="1" valign="top">&#x03b1;-CAA</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <bold>
                                    <underline>AcDDEET</underline>
                                </bold>TALVC</td>
                            <td colspan="1" rowspan="1" valign="top">Anti-&#x03b1;-CAA</td>
                            <td colspan="1" rowspan="1" valign="top">22D3</td>
                            <td colspan="1" rowspan="1" valign="top">IgG1</td>
                            <td colspan="1" rowspan="1" valign="top">
                                <xref ref-type="bibr" rid="ref-8">Driesen 
                                    <italic toggle="yes">et al.</italic>, 2009</xref>
                            </td>
                            <td colspan="1" rowspan="1" valign="top">EMD Millipore
                                <break/>Nordic-MUbio</td>
                            <td colspan="1" rowspan="1" valign="top">MABT823
                                <break/>MUB0109S</td>
                        </tr>
                    </tbody>
                </table>
            </table-wrap>
        </sec>
        <sec sec-type="materials | methods">
            <title>Materials and methods</title>
            <sec>
                <title>Reagents details</title>
                <p>Details of all reagents with reference to the immunoblot and immunostaining procedure can be found in 
                    <xref ref-type="table" rid="T2">Table 2</xref> and 
                    <xref ref-type="table" rid="T3">Table 3</xref>. Crucial are the conditions of fixation and permeabilization for relevant immunostaining. With cells in culture as well as with tissues, we have tested a large number of conditions such as MeOH, EtOH, PFA-TX100. By far, the use of PFA, followed by MeOH, as described in 
                    <xref ref-type="table" rid="T3">Table 3</xref> and previously defined (
                    <xref ref-type="bibr" rid="ref-9">Dugina 
                        <italic toggle="yes">et al.</italic>, 2009</xref>), allowed the best detection of every actin isoform, likely because of availability of the actin molecule N-terminus.</p>
                <table-wrap id="T2" orientation="portrait" position="anchor">
                    <label>Table 2. </label>
                    <caption>
                        <title>Western blot protocol for the identification of the epitopes recognized by anti-&#x03b1;-SKA (clone 10D2) and anti-&#x03b1;-CAA (clone 22D3).</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1">Protocol steps</th>
                                <th align="left" colspan="1" rowspan="1">Reagent</th>
                                <th align="left" colspan="1" rowspan="1">Concentration/
                                    <break/>dilution</th>
                                <th align="left" colspan="1" rowspan="1">Time</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td colspan="1" rowspan="1" valign="top">Migration of Purified &#x03b1;-SKA and &#x03b1;-CAA on
                                    <break/>SDS-PAGE</td>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1" valign="top">1&#x03bc;g/lane</td>
                                <td colspan="1" rowspan="1" valign="top">overnight</td>
                            </tr>
                            <tr>
                                <td colspan="1" rowspan="1" valign="top">&#x00a0;&#x00a0;&#x00a0;&#x2022; Transfer on Nitrocellulose membranes.
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; Membranes cut in strips for Ab-peptides
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;incubation.</td>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1" valign="top">2 h</td>
                            </tr>
                            <tr>
                                <td colspan="1" rowspan="1" valign="top">Preincubation of antibodies with peptides</td>
                                <td colspan="1" rowspan="1" valign="top">MAb:
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; anti-&#x03b1;-SKA (10D2)
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; anti-&#x03b1;-CAA (22D3)
                                    <break/>For details, see 
                                    <xref ref-type="table" rid="T1">Table 1</xref>
                                    <break/>
                                    <break/>Blocking Peptides (see 
                                    <xref ref-type="fig" rid="f1">Figure 1</xref>)</td>
                                <td colspan="1" rowspan="1" valign="top">
                                    <break/>1:5000
                                    <break/>1:5000
                                    <break/>
                                    <break/>
                                    <break/>100 &#x03bc;g/ml</td>
                                <td colspan="1" rowspan="1" valign="top">1 h</td>
                            </tr>
                            <tr>
                                <td colspan="1" rowspan="1" valign="top">Membranes pretreatment</td>
                                <td colspan="1" rowspan="1" valign="top">5% dried skimmed milk in TBS</td>
                                <td colspan="1" rowspan="1" valign="top">5%</td>
                                <td colspan="1" rowspan="1" valign="top">1 h</td>
                            </tr>
                            <tr>
                                <td colspan="1" rowspan="1" valign="top">Membranes Incubation with antibody-peptides</td>
                                <td colspan="1" rowspan="1" valign="top">In 0.1% TX-100/TBS</td>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1" valign="top">2 h</td>
                            </tr>
                            <tr>
                                <td colspan="1" rowspan="1" valign="top">Membranes Incubation with 2
                                    <sup>nd</sup> antibody</td>
                                <td colspan="1" rowspan="1" valign="top">Goat Anti-Mouse IgG (H+L) HRP
                                    <break/>Conjugate (BioRad) #1706516
                                    <break/>In 0.1% TX-100/TBS</td>
                                <td colspan="1" rowspan="1" valign="top">1:10&#x2019;000</td>
                                <td colspan="1" rowspan="1" valign="top">1 h</td>
                            </tr>
                            <tr>
                                <td colspan="1" rowspan="1" valign="top">HRP activity development</td>
                                <td colspan="1" rowspan="1" valign="top">ECL protocol according to (RPN
                                    <break/>2109; GE Healthcare),</td>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1" valign="top">5&#x2013;60 sec</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
                <table-wrap id="T3" orientation="portrait" position="anchor">
                    <label>Table 3. </label>
                    <caption>
                        <title>Details of immunofluorescence staining protocol.</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Protocol steps</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Reagent</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Concentration
                                    <break/>/dilution</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Time</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Catalogue
                                    <break/>Number</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td colspan="1" rowspan="1" valign="top">&#x00a0;&#x00a0;&#x00a0;&#x2022; Cryopreserved Rat muscles
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; Cryostat sections (3&#x03bc;m)</td>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1"/>
                            </tr>
                            <tr>
                                <td colspan="1" rowspan="1" valign="top">Fixation</td>
                                <td colspan="1" rowspan="1" valign="top">&#x00a0;&#x00a0;&#x00a0;&#x2022; Paraformaldehyde
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; Methanol</td>
                                <td colspan="1" rowspan="1" valign="top">1%
                                    <break/>100%</td>
                                <td colspan="1" rowspan="1" valign="top">30 min at RT
                                    <break/>5 min at &#x2013;20&#x00b0;C</td>
                                <td colspan="1" rowspan="1"/>
                            </tr>
                            <tr>
                                <td colspan="1" rowspan="1" valign="top">Staining</td>
                                <td colspan="1" rowspan="1" valign="top">Primary Abs:
                                    <break/>MAbs:
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; anti-&#x03b1;-SKA (10D2)
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; anti-&#x03b1;-CAA (22D3)
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; anti-&#x03b1;-SMA (1A4)
                                    <break/>For details, see 
                                    <xref ref-type="table" rid="T1">Table 1</xref>
                                    <break/>
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; anti-vimentin (clone V9)
                                    <break/>
                                    <italic toggle="yes">Immunogen:</italic> Purified vimentin from porcine eye lens
                                    <break/>
                                    <italic toggle="yes">Specificity:</italic> the antibody cross-reacts with
                                    <break/>vimentin in man, cow, dog, hamster, horse, rhesus
                                    <break/>and African green monkey, rabbit, rat and rat
                                    <break/>kangaroo. No cross-reaction with mouse vimentin
                                    <break/>could be demonstrated, and results on chicken
                                    <break/>specimens are contradictory.
                                    <break/>
                                    <break/>Rabbit polyclonal Ab:
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; anti-&#x03b1;-CAA (
                                    <xref ref-type="bibr" rid="ref-7">Cl&#x00e9;ment 
                                        <italic toggle="yes">et al.</italic>, 2003</xref>)</td>
                                <td colspan="1" rowspan="1" valign="top">
                                    <break/>
                                    <break/>1:50
                                    <break/>1:50
                                    <break/>1:50
                                    <break/>
                                    <break/>
                                    <break/>1:300
                                    <break/>
                                    <break/>
                                    <break/>
                                    <break/>
                                    <break/>
                                    <break/>
                                    <break/>
                                    <break/>
                                    <break/>1:100</td>
                                <td colspan="1" rowspan="1" valign="top">2 h</td>
                                <td colspan="1" rowspan="1" valign="top">
                                    <break/>
                                    <break/>Home made
                                    <break/>Home made
                                    <break/>Home made
                                    <break/>
                                    <break/>
                                    <break/>Dako #M 0725
                                    <break/>
                                    <break/>
                                    <break/>
                                    <break/>
                                    <break/>
                                    <break/>
                                    <break/>
                                    <break/>
                                    <break/>Home made</td>
                            </tr>
                            <tr>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1" valign="top">Secondary Abs (Jackson Immmunoresearch):
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; AffiniPure Goat Anti-Mouse IgG1, Alexa 488
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; AffiniPure Goat Anti-Mouse IgG1, Alexa 594
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; AffiniPure Goat Anti-Mouse IgG2a, Alexa 488
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; AffiniPure Goat Anti-Mouse IgG2a, Alexa 594
                                    <break/>&#x00a0;&#x00a0;&#x00a0;&#x2022; AffiniPure Goat Anti-Rabbit-Alexa 594</td>
                                <td colspan="1" rowspan="1" valign="top">
                                    <break/>1:200
                                    <break/>1:200
                                    <break/>1:200
                                    <break/>1:200
                                    <break/>1:100</td>
                                <td colspan="1" rowspan="1" valign="top">1 h</td>
                                <td colspan="1" rowspan="1" valign="top">
                                    <break/>115-545-205
                                    <break/>115-585-205
                                    <break/>115-545-206
                                    <break/>115-585-206
                                    <break/>111-585-144</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
            </sec>
            <sec>
                <title>Animals</title>
                <p>All animal experiments (production of antibody in mice, rat wounds, tissue samplings) were approved by and performed in accordance with the cantonal and federal veterinary authorities.</p>
            </sec>
            <sec>
                <title>Tissue details</title>
                <p>Tibialis muscle specimens from female Wistar rats older than 10 weeks were rapidly embedded in OCT compound (Tissue-Tek), snap-frozen in a beaker containing precooled liquid isopentane, immerged in liquid nitrogen, and stored at -80&#x00b0;C. For muscle repair studies, rat tibialis muscles were injured with a liquid nitrogen cooled needle, using a well-set simple rat model (
                    <xref ref-type="bibr" rid="ref-23">Rocheteau 
                        <italic toggle="yes">et al.</italic>, 2012</xref>). Muscles were taken, OCT embedded and frozen at different days after injury.</p>
            </sec>
            <sec>
                <title>Antibody production and details</title>
                <p>MAbs against &#x03b1;-SKA and &#x03b1;-CAA were prepared following the Repetitive Immunizations Multiple Sites (RIMMS) strategy (
                    <xref ref-type="bibr" rid="ref-14">Kilpatrick 
                        <italic toggle="yes">et al.</italic>, 1997</xref>). This strategy uses lymphocytes from regional draining lymph nodes and an immunization schedule significantly shorter than conventional techniques: two weeks instead of several months. Along with the use of less antigen, this approach allows to obtain hybridomas in a month.</p>
                <p>Mice were immunized with the acetylated N-terminal decapeptide of &#x03b1;-SKA (Ac-DEDETTALVC-COOH) or &#x03b1;-CAA (Ac-DDEETTALVC-COOH) conjugated with keyhole limpet haemocyanin through the cysteine peptide C-terminus (KLH, Imject Maleimide Activated carrier proteins, Pierce) according to the instructions of the manufacturer. Briefly, over a period of 10 days, 5 injections of 5 &#x03bc;g of protein (&#x03b1;-SKA or &#x03b1;-CAA peptide x KLH) emulsified in complete Freund&#x2019;s adjuvant (first injection) or with incomplete Freund&#x2019;s adjuvant (for the remaining injections) and RIBI adjuvants (Sigma-Aldrich) were given at six subcutaneous sites proximal to draining peripheral lymph nodes (PLNs) in three anesthetized six-week-old female BALB/c mice (200&#x03bc;l/mice). Two days after the final boosts, animals were sacrificed. PLNs were harvested from popliteal, superficial inguinal, axillary, and brachial lymph nodes and dissociated. Up to 1 &#x00d7; 10
                    <sup>8</sup> lymphocytes per 3 mice, were used for fusions with 2.5 &#x00d7; 10
                    <sup>7</sup> with NSO myeloma cells using 50% polyethylene glycol (PEG 1500, Sigma-Aldrich). Fused cells were plated in 24-well tissue culture plates (4000 cells/well). Hybridomas were grown in DMEM+ pyruvate, 5% FCS, 10% NCTC 109 (Sigma-Aldrich), 1&#x00d7; MEM Non-Essential Amino Acids (Gibco), 1% Hybridoma Fusion and Cloning Supplement (HFCS, Roche), penicillin/streptomycin, and 1&#x00d7; selective media hypoxanthine/aminopterin/thymidine (HAT). Supernatants were harvested after 2 weeks and screened for antibody specificity by ELISA and immunofluorescence staining (see below). Hybridomas from wells of interest were distributed into 96-well plates (1-2-5-10 cells/well) for the first limited dilution using 1&#x00d7; hypoxanthine and thymidine (HT) in place of HAT. After about 10 days of culture, wells with single clones were identified by microscope and their supernatants were harvested for screening. Positive clones were re-plated using another limited dilution for a further 10 days in DMEM containing 10% FCS and antibiotics. Clones secreting the specific mAb were expanded and frozen. Hybridoma were cultivated at post confluence in the same medium for mAb production. Sodium azide (0.1%) was added to the supernatants for storage. See 
                    <xref ref-type="table" rid="T2">Table 2</xref> and 
                    <xref ref-type="table" rid="T3">Table 3</xref> for working dilution.</p>
                <p>Supernatants of hybridoma cells secreting anti-&#x03b1;-SKA or anti-&#x03b1;-CAA were screened by: i) triple ELISA, using 96 well plates coated with &#x03b1;-SMA, &#x03b1;-SKA and &#x03b1;-CAA BSA-conjugated peptides, using Maleimide Activated BSA (Pierce) according to the instructions of the manufacturer; ii) Western blotting using platelets, heart, aorta, skeletal muscle, gizzard extracts (
                    <xref ref-type="bibr" rid="ref-8">Driesen 
                        <italic toggle="yes">et al.</italic>, 2009</xref>); iii) immunofluorescence using rat lip, skeletal and heart sections. Selected hybridomas were cloned twice by limited dilution, as described above, and the final mAB characterization was performed by immunoblotting after transfer of one-dimensional gels containing tissue and cell extracts and finally by blocking assays (
                    <xref ref-type="bibr" rid="ref-3">Chaponnier 
                        <italic toggle="yes">et al.</italic>, 1995</xref>) using the N-terminal peptides of &#x03b1;-SKA and &#x03b1;-CAA.</p>
            </sec>
            <sec>
                <title>Electrophoresis and immunoblot analysis</title>
                <p>Purified &#x03b1;-SKA (
                    <xref ref-type="bibr" rid="ref-28">Spudich &amp; Watt, 1971</xref>) and &#x03b1;-CAA (
                    <xref ref-type="bibr" rid="ref-33">Zot &amp; Potter, 1981</xref>) were run on 10% SDS-PAGE (
                    <xref ref-type="bibr" rid="ref-15">Laemmli, 1970</xref>) and electroblotted to nitrocellulose according to Towbin 
                    <italic toggle="yes">et al.</italic> (
                    <xref ref-type="bibr" rid="ref-30">Towbin 
                        <italic toggle="yes">et al.</italic>, 1979</xref>). After preincubation with the respective different length peptides (listed in 
                    <xref ref-type="fig" rid="f1">Figure 1</xref>), the antibodies, diluted in Tris-buffered saline (TBS) solution containing 3% BSA and 0.1% Triton X-100, were incubated on membranes strips for two hours at room temperature. After 3 washes with TBS, a second incubation was performed with peroxidase-conjugated affinity purified goat anti-rabbit IgG (Biorad) at a dilution of 1:10,000 in TBS containing 0.1% BSA and 0.1% Triton X-100. Peroxidase activity was developed using the ECL Western blotting system (GE Healthcare), exposed to AX Konica Minolta films for 5&#x2013;60 sec, and processed with Curix-60 developing machine (Agfa). Blots were scanned and quantified using densitometric analysis ImageJ v1.49 software (NIH, 
                    <ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij/">http://rsb.info.nih.gov/ij/</ext-link>).</p>
                <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                    <label>Figure 1. </label>
                    <caption>
                        <p>Identification, by immunoblots, of the epitope recognized by anti-&#x03b1;-SKA (
                            <bold>A</bold>) and anti-&#x03b1;-CAA (
                            <bold>B</bold>). Purified &#x03b1;-SKA (
                            <bold>A</bold>) or &#x03b1;-CAA (
                            <bold>B</bold>) was run on 10% SDS-PAGE and transferred on nitrocellulose membrane. Membrane strips were incubated with the mAb anti-&#x03b1;-SKA (
                            <bold>A</bold>) or anti-&#x03b1;-CAA (
                            <bold>B</bold>) alone (control, lane 1) or mixed with the listed peptides (2&#x2013;9). The epitope recognized by anti-&#x03b1;-SKA (
                            <bold>A</bold>) includes the acetyl group and the first 7 amino acids of the &#x03b1;-SKA sequence. The epitope recognized by anti-&#x03b1;-CAA (
                            <bold>B</bold>) includes the acetyl group and the first 5 amino acids of the &#x03b1;-CAA sequence.</p>
                    </caption>
                    <graphic orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/9468/6f85ea1d-cc25-4551-863b-928e84b4849c_figure1.gif"/>
                </fig>
            </sec>
            <sec>
                <title>Immunofluorescence microscopy</title>
                <p>Cryopreserved tissues were sliced (3 &#x03bc;m) with a cryostat microtome (Microm). Sections were positionned on glass slides, fixed with 1% PFA for 30 min at room temperature, followed by three washes with PBS and a 3 min treatment with methanol at -20&#x00b0;C. After three 5 min washes with PBS at RT, tissue sections on glass slides were incubated with primary (2h) and secondary antibodies (1h) at appropriate dilutions (see 
                    <xref ref-type="table" rid="T3">Table 3</xref>). Normal rat serum (1:50) was used to block non-specific sites, and DAPI for nuclear staining. After washing in PBS, sections on slides were mounted in polyvinyl alcohol (PVA: 50 mM Tris-phosphate pH 9.0, 0.1% chlorobutanol, 20% polyvinyl alcohol, 0.5&#x2030; phenol red, 20% glycerol) (
                    <xref ref-type="bibr" rid="ref-16">Lennette, 1978</xref>). Images were acquired using a Zeiss Axiophot microscope (Carl Zeiss), equipped with plan apochromatic 10x, 20x, or 40x objectives and a high sensibility color camera (Axiocam, Zeiss).</p>
                <p>After a careful selection of highly specific secondary antibodies against mouse subtypes, testing a large panel of these antibodies, we selected those commercialized by Jackson Immunoresearch and Southern Biotechnology.</p>
            </sec>
        </sec>
        <sec sec-type="results">
            <title>Results</title>
            <supplementary-material id="DS0" orientation="portrait" position="float" xlink:href="https://f1000researchdata.s3.amazonaws.com/datasets/8154/96994325-2021-41e5-a241-4f5094a42009_Rawdata.docx">
                <label>Raw data for Figure 1a,b</label>
                <caption/>
            </supplementary-material>
            <sec>
                <title>Identification of the epitopes recognized by the actin isoform antibodies</title>
                <p>Acetylated N-terminal peptide of different length (4&#x2013;10 amino acids) and non-acetylated N-terminal decapeptide of &#x03b1;-SKA and &#x03b1;-CAA were tested for their blocking ability of the respective mAb (
                    <xref ref-type="fig" rid="f1">Figure 1</xref>). We identified the epitope of &#x03b1;-SKA (AcDEDETTA) and of &#x03b1;-CAA (AcDDEET). The epitope of the other actin isoforms were previously identified and are listed in 
                    <xref ref-type="table" rid="T1">Table 1</xref> (in bold letters). Noteworthy, the acetyl group is a critical element of the epitope of each isoform.</p>
            </sec>
            <sec>
                <title>Comparison of distribution of &#x03b1;-SKA and &#x03b1;-CAA, in mature skeletal muscle</title>
                <p>The normal myonuclear turnover in rodents is estimated at 1&#x2013;2% per week (
                    <xref ref-type="bibr" rid="ref-25">Schmalbruch &amp; Lewis, 2000</xref>). As a first investigation, we have compared the distribution of &#x03b1;-CAA with &#x03b1;-SKA, &#x03b1;-SMA and vimentin on cryostat sections of adult rat tibialis muscle. Although a minority of myocytes expressed &#x03b1;-CAA, we have observed two types of &#x03b1;-CAA positive cells in skeletal fibers: one was mainly located in interstitial connective tissue (
                    <xref ref-type="fig" rid="f2">Figure 2A, a&#x2013;c, d&#x2013;f</xref>) and the other was localized in the muscle mass (
                    <xref ref-type="fig" rid="f2">Figure 2A, g&#x2013;i</xref>, arrowhead). The first type corresponded most likely the &#x201c;muscle spindles&#x201d;, described by Moll 
                    <italic toggle="yes">et al.</italic> (
                    <xref ref-type="bibr" rid="ref-20">Moll 
                        <italic toggle="yes">et al.</italic>, 2006</xref>), as &#x201c;modified muscle fibers of neuromuscular spindles, believed to act as sensors of muscle tension&#x201d;. The &#x201c;spindle&#x201d; cells expressed exclusively &#x03b1;-CAA, whereas the &#x201c;classical muscle fibers&#x201d;, in addition to a high expression of &#x03b1;-CAA, displayed &#x03b1;-SKA at various levels (
                    <xref ref-type="fig" rid="f2">Figure 2A, g&#x2013;i, j&#x2013;l</xref>), probably according to the state of differentiation during self-regeneration of myocytes.</p>
                <fig fig-type="figure" id="f2" orientation="portrait" position="float">
                    <label>Figure 2. </label>
                    <caption>
                        <title>Rat adult skeletal muscle co-stained with isoform specific antibodies.</title>
                        <p>
                            <bold>A</bold>) Co-staining with anti-&#x03b1;-SKA (red) and anti-&#x03b1;-CAA (green) allows the detection of isolated thin &#x03b1;-CAA positive fibers in interstitial connective tissue (transversal sections, a&#x2013;c: longitudinal section, d&#x2013;f) and of regenerating muscle fibers expressing both isoforms (longitudinal section, g&#x2013;l, arrowhead), or only &#x03b1;-CAA (arrow). Merged images are shown on right column. Bars = 50 &#x03bc;m. 
                            <bold>B</bold>) Co-staining with anti-&#x03b1;-CAA (green) and anti-&#x03b1;-SMA (red) shows that &#x03b1;-CAA positive spindle cells are in close connection with &#x03b1;-SMA positive vessel (a&#x2013;c), that early muscle fiber self-regeneration is characterized by co-expression of both isoform (d&#x2013;f, arrowhead), although more advanced regenerated fibers are only &#x03b1;-CAA positive (g&#x2013;i). Merged images are shown on right column. Bar = 50 &#x03bc;m. 
                            <bold>C</bold>) Co-staining with anti-&#x03b1;-CAA (red) and anti-vimentin (green) allows the detection of &#x03b1;-CAA positive muscle spindle cells surrounded by a capsule containing vimentin positive cells (transversal section, a&#x2013;c) and of regenerating &#x03b1;-CAA positive fibers in contact with vimentin positive cells (longitudinal section, d&#x2013;f). Merged images are shown on right column. Bar = 50 &#x03bc;m.</p>
                    </caption>
                    <graphic orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/9468/6f85ea1d-cc25-4551-863b-928e84b4849c_figure2.gif"/>
                </fig>
                <p>It is well known that during skeletal muscle development, &#x03b1;-SMA is the first muscle actin to be expressed in myocytes during fetal life. Therefore, we also investigated the expression of &#x03b1;-SMA during muscle self-regeneration. We observed that a few regenerating &#x03b1;-CAA positive fibers displayed &#x03b1;-SMA (
                    <xref ref-type="fig" rid="f2">Figure 2B, d&#x2013;f</xref>).</p>
                <p>As vimentin is expressed in the capsule of muscle spindle cells (
                    <xref ref-type="bibr" rid="ref-5">Cizkov&#x00e1; 
                        <italic toggle="yes">et al.</italic>, 2009</xref>), we investigated further whether the &#x03b1;-CAA positive fibers located in interstitial spaces could be identified as component of muscle spindles. After co-staining of muscle sections for &#x03b1;-CAA and vimentin, we confirmed that a capsule containing vimentin-positive cells surrounded isolated &#x03b1;-CAA positive spindle fibers (
                    <xref ref-type="fig" rid="f2">Figure 2C, a&#x2013;c</xref>). Noteworthy, regenerating fibers displayed contacts with vimentin positive cells (
                    <xref ref-type="fig" rid="f2">Figure 2C, d&#x2013;f</xref>).</p>
            </sec>
            <sec>
                <title>Distribution of &#x03b1;-SMA, &#x03b1;-SKA and &#x03b1;-CAA, in mature skeletal muscle during the repair process</title>
                <p>The use of specific mAbs against actin isoforms allows the tracking and follow-up of myocytes regeneration during the muscle repair process. In particular, complete and fast repair can be observed after muscle micro-lesions obtained after light injury induced by nitrogen-cooled needle application. At early stage (4 day post-injury), an important population of &#x03b1;-CAA positive myofibers was observed (
                    <xref ref-type="fig" rid="f3">Figure 3A</xref>) at injury sites. These cells, being &#x03b1;-SKA negative or marginally positive, are probably in an early stage of differentiation. Few of them co-expressed &#x03b1;-SMA (
                    <xref ref-type="fig" rid="f3">Figure 3C, a&#x2013;c</xref>, arrowhead). Only rarely, &#x03b1;-SMA positive myofibroblasts, the hallmark of fibrotic process (
                    <xref ref-type="bibr" rid="ref-29">Tomasek 
                        <italic toggle="yes">et al.</italic>, 2002</xref>) were detected (
                    <xref ref-type="fig" rid="f3">Figure 3C, a&#x2013;c</xref>, arrow). At 5d post-injury, fibers started to express more importantly &#x03b1;-SKA in addition to &#x03b1;-CAA in the regenerating location (
                    <xref ref-type="fig" rid="f3">Figure 3B, a&#x2013;f</xref>). In our model, muscle regeneration was very rapid, as expression of &#x03b1;-SMA was not any longer detectable 5d after injury (
                    <xref ref-type="fig" rid="f3">Figure 3C, d&#x2013;f</xref>). At 9d post-injury, co-expression of &#x03b1;-SKA and &#x03b1;-CAA became rare (
                    <xref ref-type="fig" rid="f3">Figure 3B, g&#x2013;i</xref>). These results suggest that skeletal muscle has a high capacity of regeneration after micro-injury and that actin isoform specific mAbs represent an important tool for muscle regeneration tracking.</p>
                <fig fig-type="figure" id="f3" orientation="portrait" position="float">
                    <label>Figure 3. </label>
                    <caption>
                        <title>Regenerating rat adult skeletal muscle co-stained with isoform specific antibodies.</title>
                        <p>
                            <bold>A</bold>) At 4d post-injury, co-staining with anti-&#x03b1;-SKA (red) and anti-&#x03b1;-CAA (green) shows the presence of &#x03b1;-CAA positive fibers in the injured muscle area (a&#x2013;i). At this stage of regeneration, only a few fibers co-express both isoforms (d&#x2013;i), with a low &#x03b1;-SKA level (g&#x2013;i). Merged images are shown on right column. Bars = 50 &#x03bc;m. 
                            <bold>B</bold>) At 5d&#x2013;9d post-injury, co-staining with anti-&#x03b1;-SKA (red) and anti-&#x03b1;-CAA (green) shows that after 5d, most fibers co-express both isoforms (a&#x2013;f), whereas at 9d (g&#x2013;i), &#x03b1;-SKA positive fibers become predominant. Merged images are shown on right column. Bars = 50 &#x03bc;m. 
                            <bold>C</bold>) At 4d&#x2013;5d post-injury, co-staining with anti-&#x03b1;-SMA (red) and anti-&#x03b1;-CAA (green) shows that during the healing process, only a few fibers co-express both isoforms after 4d (a&#x2013;c, arrowhead), whereas after 5d, only &#x03b1;-CAA positive fibers are detected (d&#x2013;f). After 4d, myofibroblasts might participate to the repair process and are detected by using the anti-&#x03b1;- SMA mAb (a&#x2013;c, arrow). Merged images are shown on right column. Bars = 50 &#x03bc;m.</p>
                    </caption>
                    <graphic orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/9468/6f85ea1d-cc25-4551-863b-928e84b4849c_figure3.gif"/>
                </fig>
            </sec>
        </sec>
        <sec sec-type="conclusions">
            <title>Conclusion</title>
            <p>In conclusion, &#x03b1;-CAA, in conjunction with the expression of &#x03b1;-SMA and &#x03b1;-SKA, appears to represent a valuable marker for the identification of myofibers regeneration in skeletal muscle and for the analysis of the degree of fiber differentiation. For this purpose, it is important to use well-characterized and specific antibodies. Furthermore, high quality anti-mouse subtype secondary antibodies allow double immunostaining necessary for this type of investigation.</p>
        </sec>
        <sec>
            <title>Data availability</title>
            <p>The data referenced by this article are under copyright with the following copyright statement: Copyright: &#x00ef;&#x00bf;&#x00bd; 2016 Chaponnier C and Gabbiani G</p>
            <p>Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
                <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"/>
            </p>
            <p>
                <italic toggle="yes">F1000Researc</italic>h: Dataset 1. Raw data for 
                <xref ref-type="fig" rid="f1">Figures 1a, b</xref>., 
                <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5256/f1000research.8154.d117164">10.5256/f1000research.8154.d117164</ext-link> (
                <xref ref-type="bibr" rid="ref-4">Chaponnier &amp; Gabbiani, 2016</xref>).</p>
        </sec>
    </body>
    <back>
        <ack>
            <title>Acknowledgments</title>
            <p>We thank Anita Hiltbrunner and Aman Ahmed Mohamed, for their high quality technical assistance, Dr. Marie-Luce Bochaton-Piallat for advice and help with Photoshop and Dr. St&#x00e9;phane K&#x00f6;nig, Department of Basic Neurosciences, for advice and discussion about the muscle micro-lesion model.</p>
        </ack>
        <sec>
            <title>Supplemental Figures</title>
            <fig fig-type="figure" id="SF1" orientation="portrait" position="float">
                <label>Supplemental Figure 1. </label>
                <caption>
                    <title>Immunodetection of &#x03b1;-CAA and &#x03b1;-SKA in total tissue extracts by Western blots.</title>
                    <p>Coomassie Blue (CB) staining of bovine aorta (A), rat heart (B), rat skeletal muscle (C), human platelets (D), and chicken gizzard (E) total extracts. Immunodetection of total actin, &#x03b1;-CAA and &#x03b1;-SKA with specific mAbs in total extracts of the same tissues.</p>
                </caption>
                <graphic orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/9468/6f85ea1d-cc25-4551-863b-928e84b4849c_suppl_figure1.gif"/>
            </fig>
            <fig fig-type="figure" id="SF2" orientation="portrait" position="float">
                <label>Supplemental Figure 2. </label>
                <caption>
                    <p>Enlargement of 
                        <xref ref-type="fig" rid="f2">Figure 2Af</xref> (
                        <bold>a</bold>) and 
                        <xref ref-type="fig" rid="f3">Figure 3Ai</xref> (
                        <bold>b</bold>), showing that, either in normal adult muscle (
                        <bold>a</bold>), or at 4d post-injury during the healing process (
                        <bold>b</bold>), regenerating &#x03b1;CAA (green) positive myofibers with centrally located nuclei (blue) are detectable. Differentiated muscles express &#x03b1;SKA (red) with peripheral located nuclei (blue) in both situations.</p>
                </caption>
                <graphic orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/9468/6f85ea1d-cc25-4551-863b-928e84b4849c_suppl_figure2.gif"/>
            </fig>
        </sec>
        <ref-list>
            <ref id="ref-1">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Arnoldi</surname>
                            <given-names>R</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Hiltbrunner</surname>
                            <given-names>A</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Dugina</surname>
                            <given-names>V</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>Smooth muscle actin isoforms: a tug of war between contraction and compliance.</article-title>
                    <source>
						
                        <italic toggle="yes">Eur J Cell Biol.</italic>
					</source>
                    <year>2013</year>;<volume>92</volume>(<issue>6&#x2013;7</issue>):<fpage>187</fpage>&#x2013;<lpage>200</lpage>.
                    <pub-id pub-id-type="pmid">23915964</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.ejcb.2013.06.002</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-2">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Bochaton-Piallat</surname>
                            <given-names>M</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Ropraz</surname>
                            <given-names>P</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Gabbiani</surname>
                            <given-names>G</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>Actin isoform and intermediate filament protein expression in human developing skeletal muscle.</article-title>
                    <source>
						
                        <italic toggle="yes">Basic Appl Myol.</italic>
					</source>
                    <year>1992</year>;<volume>2</volume>(<issue>2</issue>):<fpage>83</fpage>&#x2013;<lpage>87</lpage>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.google.co.in/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=1&amp;ved=0ahUKEwi0zOirjMfLAhXBSI4KHfHYBIMQFggeMAA&amp;url=http%3A%2F%2Fwww.bio.unipd.it%2Fbam%2FPDF%2F2-2%2FBochaton-Piallat.pdf&amp;usg=AFQjCNHuPROAm37nY1Sk3kIuOe_w319usQ&amp;bvm=bv.117218890,d.c2E&amp;cad=rja">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-3">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Chaponnier</surname>
                            <given-names>C</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Goethals</surname>
                            <given-names>M</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Janmey</surname>
                            <given-names>PA</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>The specific NH2-terminal sequence Ac-EEED of alpha-smooth muscle actin plays a role in polymerization 
                        <italic toggle="yes">in vitro</italic> and 
                        <italic toggle="yes">in vivo</italic>.</article-title>
                    <source>
						
                        <italic toggle="yes">J Cell Biol.</italic>
					</source>
                    <year>1995</year>;<volume>130</volume>(<issue>4</issue>):<fpage>887</fpage>&#x2013;<lpage>95</lpage>.
                    <pub-id pub-id-type="pmid">7543902</pub-id>
                    <pub-id pub-id-type="doi">10.1083/jcb.130.4.887</pub-id>
                    <pub-id pub-id-type="pmcid">2199961</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-4">
                <mixed-citation publication-type="data">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Chaponnier</surname>
                            <given-names>C</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Gabbiani</surname>
                            <given-names>G</given-names>
                        </name>
					</person-group>:
                    <article-title>Dataset 1 in: Monoclonal antibodies against muscle actin isoforms: epitope identification and analysis of isoform expression by immunoblot and immunostaining in normal and regenerating skeletal muscle.</article-title>
                    <source>
						
                        <italic toggle="yes">F1000Research.</italic>
					</source>
                    <year>2016</year>.
                    <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5256/f1000research.8154.d117164">Data Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-5">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Cizkov&#x00e1;</surname>
                            <given-names>D</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Soukup</surname>
                            <given-names>T</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Mokr&#x00fd;</surname>
                            <given-names>J</given-names>
                        </name>
					</person-group>:
                    <article-title>Expression of nestin, desmin and vimentin in intact and regenerating muscle spindles of rat hind limb skeletal muscles.</article-title>
                    <source>
						
                        <italic toggle="yes">Histochem Cell Biol.</italic>
					</source>
                    <year>2009</year>;<volume>131</volume>(<issue>2</issue>):<fpage>197</fpage>&#x2013;<lpage>206</lpage>.
                    <pub-id pub-id-type="pmid">18941770</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s00418-008-0523-7</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-6">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Cl&#x00e9;ment</surname>
                            <given-names>S</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Chaponnier</surname>
                            <given-names>C</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Gabbiani</surname>
                            <given-names>G</given-names>
                        </name>
					</person-group>:
                    <article-title>A subpopulation of cardiomyocytes expressing alpha-skeletal actin is identified by a specific polyclonal antibody.</article-title>
                    <source>
						
                        <italic toggle="yes">Circ Res.</italic>
					</source>
                    <year>1999</year>;<volume>85</volume>(<issue>10</issue>):<fpage>e51</fpage>&#x2013;<lpage>8</lpage>.
                    <pub-id pub-id-type="pmid">10559147</pub-id>
                    <pub-id pub-id-type="doi">10.1161/01.RES.85.10.e51</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-7">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Cl&#x00e9;ment</surname>
                            <given-names>S</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Orlandi</surname>
                            <given-names>A</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Bocchi</surname>
                            <given-names>L</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>Actin isoform pattern expression: a tool for the diagnosis and biological characterization of human rhabdomyosarcoma.</article-title>
                    <source>
						
                        <italic toggle="yes">Virchows Arch.</italic>
					</source>
                    <year>2003</year>;<volume>442</volume>(<issue>1</issue>):<fpage>31</fpage>&#x2013;<lpage>8</lpage>.
                    <pub-id pub-id-type="pmid">12536312</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s00428-002-0728-4</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-8">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Driesen</surname>
                            <given-names>RB</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Verheyen</surname>
                            <given-names>FK</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Debie</surname>
                            <given-names>W</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>Re-expression of alpha skeletal actin as a marker for dedifferentiation in cardiac pathologies.</article-title>
                    <source>
						
                        <italic toggle="yes">J Cell Mol Med.</italic>
					</source>
                    <year>2009</year>;<volume>13</volume>(<issue>5</issue>):<fpage>896</fpage>&#x2013;<lpage>908</lpage>.
                    <pub-id pub-id-type="pmid">19538254</pub-id>
                    <pub-id pub-id-type="doi">10.1111/j.1582-4934.2008.00523.x</pub-id>
                    <pub-id pub-id-type="pmcid">3823406</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-9">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Dugina</surname>
                            <given-names>V</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Zwaenepoel</surname>
                            <given-names>I</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Gabbiani</surname>
                            <given-names>G</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity.</article-title>
                    <source>
						
                        <italic toggle="yes">J Cell Sci.</italic>
					</source>
                    <year>2009</year>;<volume>122</volume>(<issue>Pt 16</issue>):<fpage>2980</fpage>&#x2013;<lpage>8</lpage>.
                    <pub-id pub-id-type="pmid">19638415</pub-id>
                    <pub-id pub-id-type="doi">10.1242/jcs.041970</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-10">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Franke</surname>
                            <given-names>WW</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Stehr</surname>
                            <given-names>S</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Stumpp</surname>
                            <given-names>S</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>Specific immunohistochemical detection of cardiac/fetal alpha-actin in human cardiomyocytes and regenerating skeletal muscle cells.</article-title>
                    <source>
						
                        <italic toggle="yes">Differentiation.</italic>
					</source>
                    <year>1996</year>;<volume>60</volume>(<issue>4</issue>):<fpage>245</fpage>&#x2013;<lpage>50</lpage>.
                    <pub-id pub-id-type="pmid">8765054</pub-id>
                    <pub-id pub-id-type="doi">10.1046/j.1432-0436.1996.6040245.x</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-11">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Gunning</surname>
                            <given-names>P</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Ponte</surname>
                            <given-names>P</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Blau</surname>
                            <given-names>H</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>alpha-skeletal and alpha-cardiac actin genes are coexpressed in adult human skeletal muscle and heart.</article-title>
                    <source>
						
                        <italic toggle="yes">Mol Cell Biol.</italic>
					</source>
                    <year>1983</year>;<volume>3</volume>(<issue>11</issue>):<fpage>1985</fpage>&#x2013;<lpage>95</lpage>.
                    <pub-id pub-id-type="pmid">6689196</pub-id>
                    <pub-id pub-id-type="doi">10.1128/MCB.3.11.1985</pub-id>
                    <pub-id pub-id-type="pmcid">370066</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-12">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Hayward</surname>
                            <given-names>LJ</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Schwartz</surname>
                            <given-names>RJ</given-names>
                        </name>
					</person-group>:
                    <article-title>Sequential expression of chicken actin genes during myogenesis.</article-title>
                    <source>
						
                        <italic toggle="yes">J Cell Biol.</italic>
					</source>
                    <year>1986</year>;<volume>102</volume>(<issue>4</issue>):<fpage>1485</fpage>&#x2013;<lpage>93</lpage>.
                    <pub-id pub-id-type="pmid">3007534</pub-id>
                    <pub-id pub-id-type="pmcid">2114155</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-13">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Hayward</surname>
                            <given-names>LJ</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Zhu</surname>
                            <given-names>YY</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Schwartz</surname>
                            <given-names>RJ</given-names>
                        </name>
					</person-group>:
                    <article-title>Cellular localization of muscle and nonmuscle actin mRNAs in chicken primary myogenic cultures: the induction of alpha-skeletal actin mRNA is regulated independently of alpha-cardiac actin gene expression.</article-title>
                    <source>
						
                        <italic toggle="yes">J Cell Biol.</italic>
					</source>
                    <year>1988</year>;<volume>106</volume>(<issue>6</issue>):<fpage>2077</fpage>&#x2013;<lpage>86</lpage>.
                    <pub-id pub-id-type="pmid">3384853</pub-id>
                    <pub-id pub-id-type="doi">10.1083/jcb.106.6.2077</pub-id>
                    <pub-id pub-id-type="pmcid">2115141</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-14">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Kilpatrick</surname>
                            <given-names>KE</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Wring</surname>
                            <given-names>SA</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Walker</surname>
                            <given-names>DH</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>Rapid development of affinity matured monoclonal antibodies using RIMMS.</article-title>
                    <source>
						
                        <italic toggle="yes">Hybridoma.</italic>
					</source>
                    <year>1997</year>;<volume>16</volume>(<issue>4</issue>):<fpage>381</fpage>&#x2013;<lpage>389</lpage>.
                    <pub-id pub-id-type="pmid">9309429</pub-id>
                    <pub-id pub-id-type="doi">10.1089/hyb.1997.16.381</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-15">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Laemmli</surname>
                            <given-names>UK</given-names>
                        </name>
					</person-group>:
                    <article-title>Cleavage of structural proteins during the assembly of the head of bacteriophage T4.</article-title>
                    <source>
						
                        <italic toggle="yes">Nature.</italic>
					</source>
                    <year>1970</year>;<volume>227</volume>(<issue>5259</issue>):<fpage>680</fpage>&#x2013;<lpage>685</lpage>.
                    <pub-id pub-id-type="pmid">5432063</pub-id>
                    <pub-id pub-id-type="doi">10.1038/227680a0</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-16">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Lennette</surname>
                            <given-names>DA</given-names>
                        </name>
					</person-group>:
                    <article-title>An improved mounting medium for immunofluorescence microscopy.</article-title>
                    <source>
						
                        <italic toggle="yes">Am J Clin Pathol.</italic>
					</source>
                    <year>1978</year>;<volume>69</volume>(<issue>6</issue>):<fpage>647</fpage>&#x2013;<lpage>8</lpage>.
                    <pub-id pub-id-type="pmid">27089</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-17">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>McHugh</surname>
                            <given-names>KM</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Crawford</surname>
                            <given-names>K</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Lessard</surname>
                            <given-names>JL</given-names>
                        </name>
					</person-group>:
                    <article-title>A comprehensive analysis of the developmental and tissue-specific expression of the isoactin multigene family in the rat.</article-title>
                    <source>
						
                        <italic toggle="yes">Dev Biol.</italic>
					</source>
                    <year>1991</year>;<volume>148</volume>(<issue>2</issue>):<fpage>442</fpage>&#x2013;<lpage>58</lpage>.
                    <pub-id pub-id-type="pmid">1743394</pub-id>
                    <pub-id pub-id-type="doi">10.1016/0012-1606(91)90263-3</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-18">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Minty</surname>
                            <given-names>AJ</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Alonso</surname>
                            <given-names>S</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Caravatti</surname>
                            <given-names>M</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>A fetal skeletal muscle actin mRNA in the mouse and its identity with cardiac actin mRNA.</article-title>
                    <source>
						
                        <italic toggle="yes">Cell.</italic>
					</source>
                    <year>1982</year>;<volume>30</volume>(<issue>1</issue>):<fpage>185</fpage>&#x2013;<lpage>92</lpage>.
                    <pub-id pub-id-type="pmid">6897014</pub-id>
                    <pub-id pub-id-type="doi">10.1016/0092-8674(82)90024-1</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-19">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Mizuno</surname>
                            <given-names>Y</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Suzuki</surname>
                            <given-names>M</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Nakagawa</surname>
                            <given-names>H</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>Switching of actin isoforms in skeletal muscle differentiation using mouse ES cells.</article-title>
                    <source>
						
                        <italic toggle="yes">Histochem Cell Biol.</italic>
					</source>
                    <year>2009</year>;<volume>132</volume>(<issue>6</issue>):<fpage>669</fpage>&#x2013;<lpage>72</lpage>.
                    <pub-id pub-id-type="pmid">19830444</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s00418-009-0650-9</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-20">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Moll</surname>
                            <given-names>R</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Holzhausen</surname>
                            <given-names>HJ</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Mennel</surname>
                            <given-names>HD</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>The cardiac isoform of alpha-actin in regenerating and atrophic skeletal muscle, myopathies and rhabdomyomatous tumors: an immunohistochemical study using monoclonal antibodies.</article-title>
                    <source>
						
                        <italic toggle="yes">Virchows Arch.</italic>
					</source>
                    <year>2006</year>;<volume>449</volume>(<issue>2</issue>):<fpage>175</fpage>&#x2013;<lpage>91</lpage>.
                    <pub-id pub-id-type="pmid">16715231</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s00428-006-0220-7</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-21">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Ordahl</surname>
                            <given-names>CP</given-names>
                        </name>
					</person-group>:
                    <article-title>The skeletal and cardiac alpha-actin genes are coexpressed in early embryonic striated muscle.</article-title>
                    <source>
						
                        <italic toggle="yes">Dev Biol.</italic>
					</source>
                    <year>1986</year>;<volume>117</volume>(<issue>2</issue>):<fpage>488</fpage>&#x2013;<lpage>92</lpage>.
                    <pub-id pub-id-type="pmid">3758481</pub-id>
                    <pub-id pub-id-type="doi">10.1016/0012-1606(86)90315-5</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-22">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Paterson</surname>
                            <given-names>BM</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Eldridge</surname>
                            <given-names>JD</given-names>
                        </name>
					</person-group>:
                    <article-title>alpha-Cardiac actin is the major sarcomeric isoform expressed in embryonic avian skeletal muscle.</article-title>
                    <source>
						
                        <italic toggle="yes">Science.</italic>
					</source>
                    <year>1984</year>;<volume>224</volume>(<issue>4656</issue>):<fpage>1436</fpage>&#x2013;<lpage>8</lpage>.
                    <pub-id pub-id-type="pmid">6729461</pub-id>
                    <pub-id pub-id-type="doi">10.1126/science.6729461</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-23">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Rocheteau</surname>
                            <given-names>P</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Gayraud-Morel</surname>
                            <given-names>B</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Siegl-Cachedenier</surname>
                            <given-names>I</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>A subpopulation of adult skeletal muscle stem cells retains all template DNA strands after cell division.</article-title>
                    <source>
						
                        <italic toggle="yes">Cell.</italic>
					</source>
                    <year>2012</year>;<volume>148</volume>(<issue>1&#x2013;2</issue>):<fpage>112</fpage>&#x2013;<lpage>25</lpage>.
                    <pub-id pub-id-type="pmid">22265406</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.cell.2011.11.049</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-24">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Sassoon</surname>
                            <given-names>DA</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Garner</surname>
                            <given-names>I</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Buckingham</surname>
                            <given-names>M</given-names>
                        </name>
					</person-group>:
                    <article-title>Transcripts of alpha-cardiac and alpha-skeletal actins are early markers for myogenesis in the mouse embryo.</article-title>
                    <source>
						
                        <italic toggle="yes">Development.</italic>
					</source>
                    <year>1988</year>;<volume>104</volume>(<issue>1</issue>):<fpage>155</fpage>&#x2013;<lpage>64</lpage>.
                    <pub-id pub-id-type="pmid">3075543</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-25">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Schmalbruch</surname>
                            <given-names>H</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Lewis</surname>
                            <given-names>DM</given-names>
                        </name>
					</person-group>:
                    <article-title>Dynamics of nuclei of muscle fibers and connective tissue cells in normal and denervated rat muscles.</article-title>
                    <source>
						
                        <italic toggle="yes">Muscle Nerve.</italic>
					</source>
                    <year>2000</year>;<volume>23</volume>(<issue>4</issue>):<fpage>617</fpage>&#x2013;<lpage>26</lpage>.
                    <pub-id pub-id-type="pmid">10716774</pub-id>
                    <pub-id pub-id-type="doi">10.1002/(SICI)1097-4598(200004)23:4&lt;617::AID-MUS22&gt;3.0.CO;2-Y</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-26">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Skalli</surname>
                            <given-names>O</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Gabbiani</surname>
                            <given-names>G</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Baba&#x00ef;</surname>
                            <given-names>F</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas.</article-title>
                    <source>
						
                        <italic toggle="yes">Am J Pathol.</italic>
					</source>
                    <year>1988</year>;<volume>130</volume>(<issue>3</issue>):<fpage>515</fpage>&#x2013;<lpage>31</lpage>.
                    <pub-id pub-id-type="pmid">3279794</pub-id>
                    <pub-id pub-id-type="pmcid">1880684</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-27">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Skalli</surname>
                            <given-names>O</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Ropraz</surname>
                            <given-names>P</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Trzeciak</surname>
                            <given-names>A</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.</article-title>
                    <source>
						
                        <italic toggle="yes">J Cell Biol.</italic>
					</source>
                    <year>1986</year>;<volume>103</volume>(<issue>6 Pt 2</issue>):<fpage>2787</fpage>&#x2013;<lpage>96</lpage>.
                    <pub-id pub-id-type="pmid">3539945</pub-id>
                    <pub-id pub-id-type="doi">10.1083/jcb.103.6.2787</pub-id>
                    <pub-id pub-id-type="pmcid">2114627</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-28">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Spudich</surname>
                            <given-names>JA</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Watt</surname>
                            <given-names>S</given-names>
                        </name>
					</person-group>:
                    <article-title>The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin.</article-title>
                    <source>
						
                        <italic toggle="yes">J Biol Chem.</italic>
					</source>
                    <year>1971</year>;<volume>246</volume>(<issue>15</issue>):<fpage>4866</fpage>&#x2013;<lpage>71</lpage>.
                    <pub-id pub-id-type="pmid">4254541</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-29">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Tomasek</surname>
                            <given-names>JJ</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Gabbiani</surname>
                            <given-names>G</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Hinz</surname>
                            <given-names>B</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>Myofibroblasts and mechano-regulation of connective tissue remodelling.</article-title>
                    <source>
						
                        <italic toggle="yes">Nat Rev Mol Cell Biol.</italic>
					</source>
                    <year>2002</year>;<volume>3</volume>(<issue>5</issue>):<fpage>349</fpage>&#x2013;<lpage>63</lpage>.
                    <pub-id pub-id-type="pmid">11988769</pub-id>
                    <pub-id pub-id-type="doi">10.1038/nrm809</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-30">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Towbin</surname>
                            <given-names>H</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Staehelin</surname>
                            <given-names>T</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Gordon</surname>
                            <given-names>J</given-names>
                        </name>
					</person-group>:
                    <article-title>Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.</article-title>
                    <source>
						
                        <italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
					</source>
                    <year>1979</year>;<volume>76</volume>(<issue>9</issue>):<fpage>4350</fpage>&#x2013;<lpage>4354</lpage>.
                    <pub-id pub-id-type="pmid">388439</pub-id>
                    <pub-id pub-id-type="doi">10.1073/pnas.76.9.4350</pub-id>
                    <pub-id pub-id-type="pmcid">411572</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-31">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Vandekerckhove</surname>
                            <given-names>J</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Bugaisky</surname>
                            <given-names>G</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Buckingham</surname>
                            <given-names>M</given-names>
                        </name>
					</person-group>:
                    <article-title>Simultaneous expression of skeletal muscle and heart actin proteins in various striated muscle tissues and cells. A quantitative determination of the two actin isoforms.</article-title>
                    <source>
						
                        <italic toggle="yes">J Biol Chem.</italic>
					</source>
                    <year>1986</year>;<volume>261</volume>(<issue>4</issue>):<fpage>1838</fpage>&#x2013;<lpage>43</lpage>.
                    <pub-id pub-id-type="pmid">3944112</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-32">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Woodcock-Mitchell</surname>
                            <given-names>J</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Mitchell</surname>
                            <given-names>JJ</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Low</surname>
                            <given-names>RB</given-names>
                        </name>
						
                        <etal/>
					</person-group>:
                    <article-title>Alpha-smooth muscle actin is transiently expressed in embryonic rat cardiac and skeletal muscles.</article-title>
                    <source>
						
                        <italic toggle="yes">Differentiation.</italic>
					</source>
                    <year>1988</year>;<volume>39</volume>(<issue>3</issue>):<fpage>161</fpage>&#x2013;<lpage>6</lpage>.
                    <pub-id pub-id-type="pmid">2468547</pub-id>
                    <pub-id pub-id-type="doi">10.1111/j.1432-0436.1988.tb00091.x</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-33">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
						
                        <name name-style="western">
                            <surname>Zot</surname>
                            <given-names>HG</given-names>
                        </name>
						
                        <name name-style="western">
                            <surname>Potter</surname>
                            <given-names>JD</given-names>
                        </name>
					</person-group>:
                    <article-title>Purification of actin from cardiac muscle.</article-title>
                    <source>
						
                        <italic toggle="yes">Prep Biochem.</italic>
					</source>
                    <year>1981</year>;<volume>11</volume>(<issue>4</issue>):<fpage>381</fpage>&#x2013;<lpage>95</lpage>.
                    <pub-id pub-id-type="pmid">7312832</pub-id>
                    <pub-id pub-id-type="doi">10.1080/00327488108065530</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report14123">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.9468.r14123</article-id>
            <title-group>
                <article-title>Reviewer response for version 2</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Hashimoto</surname>
                        <given-names>Naohiro</given-names>
                    </name>
                    <xref ref-type="aff" rid="r14123a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r14123a1">
                    <label>1</label>Department of Regenerative Medicine, National Institute for Longevity Sciences, National Center for Geriatrics and Gerontology, &#x014c;bu, Japan</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>2</day>
                <month>6</month>
                <year>2016</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2016 Hashimoto N</copyright-statement>
                <copyright-year>2016</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport14123" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.8154.2"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>I understand the purpose of this report is the validation of the actin isoforms antibodies.&#x00a0;Muscle biologists would like to hear answers for questions derived from this study.&#x00a0;</p>
            <p> </p>
            <p> For example: 
                <list list-type="order">
                    <list-item>
                        <p>What is a role of&#x00a0; myofibroblasts appear in regenerating muscles and disease muscles?</p>
                    </list-item>
                    <list-item>
                        <p>Does each actin isoform play a distinct role during&#x00a0; muscle regeneration?</p>
                    </list-item>
                </list> Particularly, a role of aCAA in newly formed myofibers is interesting.</p>
            <p> I expect the panel of antibodies against actin isoforms will help future studies to reveal distinct role(s) of actin isoforms in muscle regeneration.</p>
            <p>Reviewer Expertise:</p>
            <p>NA</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report13217">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.8771.r13217</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Ono</surname>
                        <given-names>Shoichiro</given-names>
                    </name>
                    <xref ref-type="aff" rid="r13217a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-4763-0398</uri>
                </contrib>
                <aff id="r13217a1">
                    <label>1</label>Department of Pathology and Department of Cell Biology, Emory University, Atlanta, GA, USA</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>12</day>
                <month>4</month>
                <year>2016</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2016 Ono S</copyright-statement>
                <copyright-year>2016</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport13217" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.8154.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Drs. Chaponnier and Gabbiani report production and validation of monoclonal antibodies that specifically recognize alpha-skeletal muscle actin (aSKA) or alpha-cardiac alpha actin (aCAA), which are different only in a few amino acids at the N-terminus. The new antibody against aSKA (10D2) is IgG2a, while anti-aCAA (22D3) is IgG1, which allows researchers to perform double staining in immunohistochemistry to distinguish these closely related actin isoforms. The validation in immunohistochemistry using rat tissues clearly demonstrates specific labeling of different subsets of cells by the isoform-specific antibodies. These antibodies should be outstanding resources to characterize actin isoform expression and subcellular localization in muscle development, regeneration, and diseases, as well as to investigate functions of actin isoforms. I have a few suggestions for a revision mostly for clarification purposes.
                <list list-type="order">
                    <list-item>
                        <p>In abstract and introduction, &#x201c;higher vertebrates&#x201d; should be more clearly defined. Classification of six actin isoforms in 3 subgroups applies to mammals and birds. It should be useful for researchers who use non-mammalian or non-avian species to state whether this classification applies to other vertebrates. A recent analysis by Gunning 
                            <italic>et al</italic>.
                            <sup>
                                <xref ref-type="bibr" rid="rep-ref-13217-1">1</xref>
                            </sup>&#x00a0;indicates that zebrafish has 10 muscle actins, suggesting some gene duplications and isoform divergence in fish.</p>
                    </list-item>
                    <list-item>
                        <p>Page 3, left column, 3
                            <sup>rd</sup> paragraph, &#x201c;sarcomers&#x201d; should be &#x201c;sarcomeres&#x201d;.</p>
                    </list-item>
                    <list-item>
                        <p>In Materials and Methods &#x201c;Antibody production and details&#x201d;, this section should also include description of how the monoclonal antibodies were prepared after the clonal selection has been completed, which should include whether the antibodies were finally prepared in culture media with or without serum or in ascites, and whether protein concentrations were determined.</p>
                    </list-item>
                    <list-item>
                        <p>Also In Materials and Methods &#x201c;Antibody production and details&#x201d;, the selection process includes screening using Western blotting using extracts from several different tissues. To improve transparency of the validation process, representative images of the Western blots preferably showing a wide molecular weight range should be included to demonstrate specificity.</p>
                    </list-item>
                </list>
            </p>
            <p>Reviewer Expertise:</p>
            <p>NA</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
        <back>
            <ref-list>
                <title>References</title>
                <ref id="rep-ref-13217-1">
                    <label>1</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>The evolution of compositionally and functionally distinct actin filaments.</article-title>
                        <source>
                            <italic>J Cell Sci</italic>
                        </source>.<year>2015</year>;<volume>128</volume>(<issue>11</issue>) :
                        <elocation-id>10.1242/jcs.165563</elocation-id>
                        <fpage>2009</fpage>-<lpage>19</lpage>
                        <pub-id pub-id-type="pmid">25788699</pub-id>
                        <pub-id pub-id-type="doi">10.1242/jcs.165563</pub-id>
                    </mixed-citation>
                </ref>
            </ref-list>
        </back>
        <sub-article article-type="response" id="comment1992-13217">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Chaponnier</surname>
                            <given-names>Christine </given-names>
                        </name>
                        <aff>University of Geneva, Switzerland</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>18</day>
                    <month>5</month>
                    <year>2016</year>
                </pub-date>
            </front-stub>
            <body>
                <p>Your careful review and suggestions for improving the report are highly appreciated. Please find below our answers to your questions. 
                    <list list-type="order">
                        <list-item>
                            <p>a) We have modified the abstract accordingly.</p>
                            <p> b) Concerning the amino acid sequences in zebrafish, the situation is very confusing. Search in databases gives the following results:</p>
                            <p> </p>
                            <p> Actin, alpha 2, smooth muscle, aorta</p>
                            <p> Danio rerio (Zebrafish) (Brachydanio rerio)</p>
                            <p> Q6DHS1-1</p>
                            <p> Ac-DDEESTALVC</p>
                            <p> </p>
                            <p> Actin, alpha cardiac muscle 1 [Danio rerio]</p>
                            <p> Q6IQR3-1</p>
                            <p> Ac-DDDETTALVC</p>
                            <p> </p>
                            <p> Actin, alpha 1, skeletal muscle</p>
                            <p> Danio rerio (Zebrafish) (Brachydanio rerio)</p>
                            <p> Q9I8V1-1</p>
                            <p> Ac-DDEETTALVC</p>
                            <p> </p>
                            <p> According to the available sequence (although not reviewed), the N-terminus sequence of alpha 1, skeletal muscle in Zebrafish is identical to the alpha cardiac actin in mammals and birds!!! Furthermore, the N-terminus of alpha 2, smooth muscle, aorta and of alpha cardiac muscle are different compared to the &#x03b1;-SMA and &#x03b1;-CAA human and bird sequence.</p>
                        </list-item>
                        <list-item>
                            <p>sarcomers changed for sarcomeres.</p>
                        </list-item>
                        <list-item>
                            <p>Additional informations have been included in the "Material and Methods" section.</p>
                            <p> </p>
                            <p> Yes the final antibody is obtained and used in &#x201c;hybridoma supernatant&#x201d; in the culture media with FCS for two reasons:</p>
                            <p> a) Ascites production is not allowed in Switzerland for years.</p>
                            <p> b) Hybridoma supernatants production is anyway privileged, as ascites are very often contaminated with unrelated antibodies with production time.</p>
                            <p> c) Protein concentration was not determined precisely (in general, between 0.1-10 &#x03bc;g/ml). However, the dilution to be used is indicated in the report.</p>
                        </list-item>
                        <list-item>
                            <p>We provide a new figure (Supplemental figure 1), with raw data of Western blots on different tissue extracts, showing the specificity of the antibodies.</p>
                        </list-item>
                    </list>
                </p>
            </body>
        </sub-article>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report13310">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.8771.r13310</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Skalli</surname>
                        <given-names>Omar</given-names>
                    </name>
                    <xref ref-type="aff" rid="r13310a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r13310a1">
                    <label>1</label>Department of Biological Sciences, Integrated Microscopy Center(IMC), University of Memphis, Memphis, TN, USA</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>11</day>
                <month>4</month>
                <year>2016</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2016 Skalli O</copyright-statement>
                <copyright-year>2016</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport13310" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.8154.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The paper by Chaponnier and Gabbiani reports the production of two monoclonal antibodies, one specific for skeletal actin and the other for cardiac actin. Being able to obtain these antibodies is a momentous accomplishment given that these two actin isoforms differ from each other by only a few amino acids. The authors rigorously demonstrate the specificity of each antibodies for their respective isoform by Western blotting and competitive assay with the immunogen. Because the antibodies are from different subtypes, they can be used by double immunofluorescence to investigate the regulation of skeletal and cardiac actin in different conditions. The authors provide stunningly beautiful immunofluorescence images that demonstrate the utility of their antibodies to pinpoint different cellular populations during skeletal muscle repair. It is to be expected that these antibodies will be extremely useful to studies questions related to cardiac and skeletal muscle physiology and pathology.</p>
            <p>Reviewer Expertise:</p>
            <p>NA</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
        <sub-article article-type="response" id="comment1993-13310">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Chaponnier</surname>
                            <given-names>Christine </given-names>
                        </name>
                        <aff>University of Geneva, Switzerland</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>18</day>
                    <month>5</month>
                    <year>2016</year>
                </pub-date>
            </front-stub>
            <body>
                <p>Your nice review and perfect understanding concerning the objectives of this report are highly appreciated.</p>
            </body>
        </sub-article>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report13281">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.8771.r13281</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Hashimoto</surname>
                        <given-names>Naohiro</given-names>
                    </name>
                    <xref ref-type="aff" rid="r13281a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r13281a1">
                    <label>1</label>Department of Regenerative Medicine, National Institute for Longevity Sciences, National Center for Geriatrics and Gerontology, &#x014c;bu, Japan</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>8</day>
                <month>4</month>
                <year>2016</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2016 Hashimoto N</copyright-statement>
                <copyright-year>2016</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport13281" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.8154.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Higher vertebrates express six different highly conserved actin isoforms.&#x00a0; The authors determined the precise localization of alpha-skeletal actin (aSKA) and alpha-cardiac actin (aCAA) in normal and regenerating rat skeletal muscles. The distinct distribution of the two alpha actin isoforms seems very interesting. However, the authors should describe the results of their immunofluorescent analysis on skeletal muscle more precisely and carefully.&#x00a0;
                <list list-type="order">
                    <list-item>
                        <p>The authors often used terms &#x201c;renewing muscle (fibers)&#x201d; and &#x201c;regenerating fibers&#x201d;.&#x00a0; However, there is no definition of them. The authors should show the presence of centrally located nuclei in those myofibers because those are found in newly formed myofibers.</p>
                    </list-item>
                    <list-item>
                        <p>The authors identified myofibroblasts in regenerating skeletal muscles as the alpha-SMA (aSMA) positive mononuclear cells. However, myoblasts also express aSMA.&#x00a0; Thus, the authors should determine the absence of myogenic lineage markers such as MyoD in those cells.</p>
                    </list-item>
                    <list-item>
                        <p>Intracellular localization of alpha actin isoforms should be shown in pictures with higher magnification in addition to the present Figure 2 and 3. Those data will provide important information suggesting different function of those actin isoforms.</p>
                    </list-item>
                    <list-item>
                        <p>The term &#x201c;self-renewal&#x201d; is used incorrectly. For examples, &#x201c;self-renewal in muscle cells&#x201d; and &#x201c;during muscle self-renewal&#x201d; are difficult to understand.&#x00a0; I wonder whether &#x201c;muscle cells&#x201d; mean muscle satellite cells, myoblasts (muscle progenitor cells), or myofibers.&#x00b0;&#x00a0; &#x201c;Muscle&#x00a0; self-renewal&#x201d; means muscle regeneration?</p>
                    </list-item>
                </list>
            </p>
            <p>Reviewer Expertise:</p>
            <p>NA</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <sub-article article-type="response" id="comment1994-13281">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Chaponnier</surname>
                            <given-names>Christine </given-names>
                        </name>
                        <aff>University of Geneva, Switzerland</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>18</day>
                    <month>5</month>
                    <year>2016</year>
                </pub-date>
            </front-stub>
            <body>
                <p>Your careful review and suggestions for improving the report are highly appreciated. Please find below our answers to your questions.</p>
                <p> &#x00a0; 
                    <list list-type="order">
                        <list-item>
                            <p>a) We have modified the text according to the suggestion using in general the term regeneration and not renewal.</p>
                            <p> b) Enlargement of Figure 2Af and 3Ai showing &#x03b1;CAA positive myofibers with centrally located nuclei during muscle regeneration. (See supplemental Figure 2)</p>
                        </list-item>
                        <list-item>
                            <p>a) The injury model used in this study is in general not accompanied by fibrotic events during the healing process. Only, in rare exceptions, as mentioned in the text, myofibroblasts were detected. We have a long experience in the &#x201c;myofibroblast history&#x201d;, and according to the &#x03b1;-SMA positivity and the cell shape, we believe that this area is composed of myofibroblasts.</p>
                            <p> </p>
                            <p> b) We agree that the absence of MyoD would validate our assumption. However, the purpose of this report is the validation of the actin isoforms antibodies and not a extensive study on muscle regeneration. We hope that muscle experts will take advantage of these tools for more advanced studies.</p>
                        </list-item>
                        <list-item>
                            <p>As indicated above, the purpose of this report is the validation of the actin isoforms antibodies. The intracellular localization of &#x03b1;-SMA, sometimes in striations, will not give clear information concerning its function in muscle regeneration.</p>
                        </list-item>
                        <list-item>
                            <p>a) See answer to point 1</p>
                            <p> </p>
                            <p> b) Future studies by experts, hopefully using the panel of antibodies against actin isoforms, will provide more information for the participation of satellite cells during the process of muscle regeneration.</p>
                        </list-item>
                    </list>
                </p>
            </body>
        </sub-article>
    </sub-article>
</article>
